280 related articles for article (PubMed ID: 26049706)
1. Magnetic resonance enterography findings as predictors of clinical outcome following antitumor necrosis factor treatment in small bowel Crohn's disease.
Gibson DJ; Murphy DJ; Smyth AE; McEvoy SH; Keegan D; Byrne K; Mulcahy HE; Cullen G; Malone DE; Doherty GA
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):956-62. PubMed ID: 26049706
[TBL] [Abstract][Full Text] [Related]
2. Impact of magnetic resonance enterography in the management of small bowel Crohn's disease.
Cheriyan DG; Slattery E; McDermott S; Kilcoyne A; Kingston C; Keegan D; Mulcahy HE; Doherty GA; Malone DE; Murphy SJ
Eur J Gastroenterol Hepatol; 2013 May; 25(5):550-5. PubMed ID: 23325284
[TBL] [Abstract][Full Text] [Related]
3. The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity.
Eder P; Katulska K; Krela-Kaźmierczak I; Stawczyk-Eder K; Klimczak K; Szymczak A; Linke K; Łykowska-Szuber L
Abdom Imaging; 2015 Oct; 40(7):2210-8. PubMed ID: 26048698
[TBL] [Abstract][Full Text] [Related]
4. Findings of ulceration and severe stricture on MRE can predict prognosis of Crohn's disease in patients treated with anti-TNF treatment.
Naganuma M; Okuda S; Hisamatsu T; Matsuoka K; Mori K; Hosoe N; Nakazato Y; Ogata H; Kanai T
Abdom Radiol (NY); 2017 Jan; 42(1):141-151. PubMed ID: 27549100
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance enterography for predicting the clinical course of Crohn's disease strictures.
Schulberg JD; Wright EK; Holt BA; Sutherland TR; Hume SJ; Hamilton AL; Ross AL; Connell WC; Brown SJ; Lust M; Miller AM; Bell SJ; Kamm MA
J Gastroenterol Hepatol; 2020 Jun; 35(6):980-987. PubMed ID: 31674069
[TBL] [Abstract][Full Text] [Related]
6. Small intestinal contrast ultrasonography for the detection of small bowel complications in Crohn's disease: correlation with intraoperative findings and magnetic resonance enterography.
Kumar S; Hakim A; Alexakis C; Chhaya V; Tzias D; Pilcher J; Vlahos J; Pollok R
J Gastroenterol Hepatol; 2015 Jan; 30(1):86-91. PubMed ID: 25168482
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
[TBL] [Abstract][Full Text] [Related]
8. Changes in dynamic contrast-enhanced pharmacokinetic and diffusion-weighted imaging parameters reflect response to anti-TNF therapy in Crohn's disease.
Bhatnagar G; Dikaios N; Prezzi D; Vega R; Halligan S; Taylor SA
Br J Radiol; 2015; 88(1055):20150547. PubMed ID: 26402217
[TBL] [Abstract][Full Text] [Related]
9. Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics.
Jauregui-Amezaga A; Rimola J; Ordás I; Rodríguez S; Ramírez-Morros A; Gallego M; Masamunt MC; Llach J; González-Suárez B; Ricart E; Panés J
Gut; 2015 Sep; 64(9):1397-402. PubMed ID: 25516418
[TBL] [Abstract][Full Text] [Related]
10. MR enterography-histology comparison in resected pediatric small bowel Crohn disease strictures: can imaging predict fibrosis?
Barkmeier DT; Dillman JR; Al-Hawary M; Heider A; Davenport MS; Smith EA; Adler J
Pediatr Radiol; 2016 Apr; 46(4):498-507. PubMed ID: 26638000
[TBL] [Abstract][Full Text] [Related]
11. Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease.
Deepak P; Fletcher JG; Fidler JL; Barlow JM; Sheedy SP; Kolbe AB; Harmsen WS; Loftus EV; Hansel SL; Becker BD; Bruining DH
Am J Gastroenterol; 2016 Jul; 111(7):997-1006. PubMed ID: 27166131
[TBL] [Abstract][Full Text] [Related]
12. Antitumor necrosis factor α is more effective than conventional medical therapy for the prevention of postoperative recurrence of Crohn's disease: a meta-analysis.
Nguyen DL; Solaimani P; Nguyen ET; Jamal MM; Bechtold ML
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1152-9. PubMed ID: 25089549
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Rescue Therapy in Crohn's Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-Up.
Fischer M; Campbell SC; Calley CSJ; Helper DJ; Chiorean MV; Fadda HM
Dig Dis Sci; 2017 Nov; 62(11):3131-3137. PubMed ID: 28986660
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment magnetic resonance enterography findings predict the response to TNF-alpha inhibitors in Crohn's disease.
Rimola J; Fernàndez-Clotet A; Capozzi N; Rojas-Farreras S; Alfaro I; Rodríguez S; Masamunt MC; Ricart E; Ordás I; Panés J
Aliment Pharmacol Ther; 2020 Nov; 52(10):1563-1573. PubMed ID: 32886809
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of a new endoscopic scoring system for Crohn's disease.
Morise K; Ando T; Watanabe O; Nakamura M; Miyahara R; Maeda O; Ishiguro K; Hirooka Y; Goto H
World J Gastroenterol; 2015 Sep; 21(34):9974-81. PubMed ID: 26379402
[TBL] [Abstract][Full Text] [Related]
16. Small-Bowel Crohn Disease Treated With Anti-Tumor Necrosis Factor-α Therapy: MR Enterography Score Changes After 1 Year Predict Long-Term Outcomes.
Gallego JC; de Juan C; Echarri A; Lopez-de-Ullibarri I
AJR Am J Roentgenol; 2019 Dec; 213(6):1240-1246. PubMed ID: 31414894
[No Abstract] [Full Text] [Related]
17. Diagnostic and therapeutic impact of MR enterography in Crohn's disease.
Hafeez R; Punwani S; Boulos P; Bloom S; McCartney S; Halligan S; Taylor SA
Clin Radiol; 2011 Dec; 66(12):1148-58. PubMed ID: 21943719
[TBL] [Abstract][Full Text] [Related]
18. Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort Study.
Ma C; Beilman CL; Huang VW; Fedorak DK; Kroeker KI; Dieleman LA; Halloran BP; Fedorak RN
Inflamm Bowel Dis; 2016 Apr; 22(4):870-9. PubMed ID: 26818419
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study.
Zorzi F; Zuzzi S; Onali S; Calabrese E; Condino G; Petruzziello C; Ascolani M; Pallone F; Biancone L
Aliment Pharmacol Ther; 2012 Jun; 35(12):1397-407. PubMed ID: 22519466
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
